最小侵襲脊椎技術の世界市場の評価：技術別、症状別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

世界の最小侵襲脊椎技術の市場規模は、予測期間中にCAGR 9.36％で成長し、2023年の12億1,000万米ドルから、2031年には24億8,000万米ドルに成長すると予測されています。

最小侵襲脊椎技術の市場は、最小侵襲手術に対する需要の高まり、脊椎疾患の有病率の上昇、患者の安全性とコンプライアンスの向上、手術ツール技術の進歩などの要因の影響下で成長すると予測されています。

最小侵襲脊椎手術の需要拡大

最小侵襲脊椎手術の需要は、高度な技術、疼痛管理の改善、経済的配慮などさまざまな要因によって増加しています。低侵襲脊椎手術の現在、著しい技術的進歩を遂げており、これらのアプローチはさまざまな脊椎疾患の管理により効率的で効果的なものとなっています。最小侵襲脊椎手術は、術中の出血量や術後の痛みを減らし、機能をより早く回復させることにつながります。主要企業は、増大する需要に対応するため、積極的に製品を発表しています。

脊椎疾患の有病率の増加

最小侵襲脊椎技術の市場は、脊椎疾患の有病率の増加により拡大が見込まれています。高齢者層は、加齢に伴う脊椎の摩耗や損傷により、脊椎疾患にかかりやすくなっています。そのため、脊椎障害の症例が大幅に増加すると予想されます。肥満、社会人の長時間の座位、栄養不足、運動不足、脊椎損傷につながる事故の多発などの要因も脊椎障害の有病率の高さに寄与していると考えられています。

最小侵襲脊椎手術の技術的進歩

最小侵襲脊椎手術は、近年著しい技術的進歩を遂げています。もっとも重要な技術開発として、脊椎手術における内視鏡の採用、ナビゲーション誘導脊椎固定術、脊椎手術におけるOアームナビゲーションなどがあります。技術の進歩に伴い、低侵襲脊椎手術は単純な脊柱管狭窄症や、転移、外傷、成人脊柱変形などの複雑な脊柱病理にもその有用性を広げています。ロボットシステムは脊椎手術の大きな部分を占めるようになると予想されます。市場の主要参入事業者による革新的なソリューションを生み出すためのR&Rが市場の需要を牽引しています。

当レポートでは、世界の最小侵襲脊椎技術の市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の最小侵襲脊椎技術市場の展望

• 市場規模・予測
• 技術別
  • 内視鏡検査
  • ナビゲーション
  • ロボット工学
• 症状別
  • 椎間板ヘルニア
  • 脊柱管狭窄症
  • 椎間板変性疾患
  • 脊椎変形
  • 脊椎骨折
  • 脊髄感染症
  • 脊髄腫瘍
• エンドユーザー別
  • 病院
  • 外来手術センター
  • 整形外科クリニック
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • 南米
  • 中東・アフリカ
• 企業別市場シェア

第5章 世界の最小侵襲脊椎技術市場の展望：地域別

• 北米
• 欧州
• アジア太平洋
• 南米
• 中東・アフリカ

第6章 市場マッピング

• 技術別
• 症状別
• エンドユーザー別
• 地域別

第7章 マクロ環境と産業構造

• 需給分析
• 輸出入分析
• バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第8章 市場力学

• 成長促進要因
• 成長抑制要因（課題、抑制要因）

第9章 規制の枠組みとイノベーション

• 臨床試験
• 特許の情勢
• 規制当局の承認
• イノベーション/最新技術

第10章 主要企業の情勢

• 市場リーダー上位5社の競合マトリックス
• 市場リーダー上位5社の市場収益分析
• M&A・ジョイントベンチャー (該当する場合)
• SWOT分析 (参入5社)

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

• B. Braun SE
• Boston Scientific Corporation
• Globus Medical, Inc.
• Medtronic plc
• Precision Spine, Inc.
• Richard Wolf GmbH
• Stryker Corporation
• Intuitive Surgical, Inc.
• Zimmer Biomet Holdings, Inc.
• Johnson & Johnson Services, Inc.

第13章 戦略的提言

第14章 当社について・免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 2. Global Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 3. Global Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 4. Global Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 5. Global Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 6. Global Minimally Invasive Spine Technologies Market Share (%), By Region, 2017-2031F
• Figure 7. North America Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 8. North America Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 9. North America Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 10. North America Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 11. North America Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 12. North America Minimally Invasive Spine Technologies Market Share (%), By Country, 2017-2031F
• Figure 13. United States Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 14. United States Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 15. United States Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 16. United States Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 17. United States Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 18. Canada Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 19. Canada Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 20. Canada Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 21. Canada Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 22. Canada Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 23. Mexico Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 24. Mexico Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 25. Mexico Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 26. Mexico Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 27. Mexico Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 28. Europe Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 29. Europe Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 30. Europe Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 31. Europe Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 32. Europe Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 33. Europe Minimally Invasive Spine Technologies Market Share (%), By Country, 2017-2031F
• Figure 34. Germany Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 35. Germany Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 36. Germany Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 37. Germany Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 38. Germany Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 39. France Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 40. France Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 41. France Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 42. France Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 43. France Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 44. Italy Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 45. Italy Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 46. Italy Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 47. Italy Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 48. Italy Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 49. United Kingdom Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 50. United Kingdom Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 51. United Kingdom Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 52. United Kingdom Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 53. United Kingdom Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 54. Russia Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 55. Russia Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 56. Russia Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 57. Russia Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 58. Russia Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 59. Netherlands Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 60. Netherlands Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 61. Netherlands Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 62. Netherlands Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 63. Netherlands Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 64. Spain Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 65. Spain Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 66. Spain Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 67. Spain Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 68. Spain Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 69. Turkey Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 70. Turkey Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 71. Turkey Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 72. Turkey Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 73. Turkey Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 74. Poland Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 75. Poland Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 76. Poland Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 77. Poland Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 78. Poland Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 79. South America Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 80. South America Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 81. South America Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 82. South America Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 83. South America Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 84. South America Minimally Invasive Spine Technologies Market Share (%), By Country, 2017-2031F
• Figure 85. Brazil Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 86. Brazil Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 87. Brazil Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 88. Brazil Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 89. Brazil Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 90. Argentina Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 91. Argentina Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 92. Argentina Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 93. Argentina Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 94. Argentina Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 95. Asia-Pacific Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 96. Asia-Pacific Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 97. Asia-Pacific Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 98. Asia-Pacific Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 99. Asia-Pacific Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 100. Asia-Pacific Minimally Invasive Spine Technologies Market Share (%), By Country, 2017-2031F
• Figure 101. India Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 102. India Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 103. India Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 104. India Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 105. India Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 106. China Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 107. China Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 108. China Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 109. China Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 110. China Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 111. Japan Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 112. Japan Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 113. Japan Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 114. Japan Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 115. Japan Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 116. Australia Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 117. Australia Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 118. Australia Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 119. Australia Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 120. Australia Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 121. Vietnam Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 122. Vietnam Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 123. Vietnam Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 124. Vietnam Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 125. Vietnam Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 126. South Korea Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 127. South Korea Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 128. South Korea Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 129. South Korea Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 130. South Korea Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 131. Indonesia Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 132. Indonesia Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 133. Indonesia Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 134. Indonesia Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 135. Indonesia Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 136. Philippines Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 137. Philippines Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 138. Philippines Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 139. Philippines Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 140. Philippines Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 141. Middle East & Africa Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 142. Middle East & Africa Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 143. Middle East & Africa Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 144. Middle East & Africa Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 145. Middle East & Africa Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 146. Middle East & Africa Minimally Invasive Spine Technologies Market Share (%), By Country, 2017-2031F
• Figure 147. Saudi Arabia Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 148. Saudi Arabia Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 149. Saudi Arabia Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 150. Saudi Arabia Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 151. Saudi Arabia Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 152. UAE Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 153. UAE Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 154. UAE Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 155. UAE Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 156. UAE Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 157. South Africa Minimally Invasive Spine Technologies Market, By Value, in USD Billion, 2017-2031F
• Figure 158. South Africa Minimally Invasive Spine Technologies Market, By Volume, in Thousand Units, 2017-2031F
• Figure 159. South Africa Minimally Invasive Spine Technologies Market Share (%), By Technique, 2017-2031F
• Figure 160. South Africa Minimally Invasive Spine Technologies Market Share (%), By Condition, 2017-2031F
• Figure 161. South Africa Minimally Invasive Spine Technologies Market Share (%), By End-user, 2017-2031F
• Figure 162. By Technique Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 163. By Condition Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 164. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 165. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Global minimally invasive spine technologies market is projected to witness a CAGR of 9.36% during the forecast period 2024-2031, growing from USD 1.21 billion in 2023 to USD 2.48 billion in 2031F. The minimally invasive spine technologies market is anticipated to thrive under the influence of factors such as the growing demand for minimally invasive surgeries, the rising prevalence of spine disorders, enhanced patient safety and compliance through such surgeries, and technological advancements in surgical tools.

Minimally invasive spine technologies refer to surgical techniques and technologies that aim to minimize surgical morbidity and achieve surgical outcomes as traditional open surgery while reducing iatrogenic tissue trauma and postoperative pain and disability in spine surgeries. Minimally invasive spine technologies have expanded their utility to simple spinal stenosis and complex spinal pathologies such as metastasis, trauma, or adult spinal deformity. The techniques and technology in minimally invasive spine technologies include spinal endoscopy, intraoperative fluoroscopy/CT, and minimally invasive spinal instrumentation technologies.

In upcoming years, the demand for minimally invasive spine surgeries is expected to grow owing to its multifactorial advantages, such as reduced hospital stay, lesser trauma, and faster recovery, which ultimately expands the growth of the minimally invasive spine technologies market.

However, the major challenge to the market is the high cost of instruments used and the complexities of procedures. Strict regulatory requirements and approval processes for such surgeries are tricky for manufacturers. Challenges associated with adopting robotics and technology in surgery hinder market growth. Lack of technical expertise and training modules associated with minimally invasive surgeries is another major challenge for the market.

In January 2024, Providence Medical Technology announced FDA approval of CAVUX FFS-LX Lumbar Facet Fixation System for 1st and 2nd level lumbar spinal fusion. CAVUX FFS-LX is a bilateral implant system for treating lumbar degenerative disc disease. It is a cage and screw system that provides stabilization for first or second-level lumbar interbody fusion. It can be used with or without pedicle screws and rods and is implanted using the CORUS Spinal System-LX.

Growing Demand for Minimally Invasive Spine Surgeries

The demand for minimally invasive spine surgeries is increasing due to various factors such as advanced techniques, improved pain management, and economic considerations. The current state of minimally invasive spine surgery has witnessed significant technological advancements, making these approaches more efficient and effective for managing different spinal disorders. The emergence of outpatient minimally invasive spine surgery is driven by the need to balance the desire to treat patients with a clear understanding of the economic implications of healthcare. The cost of surgery must be weighed against the societal cost of back pain, which is quite high. Minimally invasive spine surgeries are associated with reduced intraoperative blood loss, postoperative pain, and greater and earlier restoration of function. Key players actively make product launches to cater to the growing demand.

For instance, in December 2023, Ulrich Medica USA announced that it got FDA clearance to expand indications for its Momemtum and Momentum minimally invasive posterior spine systems. The systems can be used with G21 V-STEADY radiopaque bone cement to stabilize, fix, and correct the thoracolumbar and sacroiliac spine.

Growing Prevalence of Spine Disorders

The minimally invasive spine technologies market is expected to expand due to the increasing prevalence of spinal disorders. The elderly population is more susceptible to spinal disorders due to wear and tear of the spine that comes with aging. It is expected to lead to a significant increase in spinal disorder cases. Factors such as obesity, long hours of sitting among working professionals, nutritional deficiencies, lack of physical exercise, and a high number of accidents leading to spinal injuries are expected to contribute to a high prevalence of spinal disorders. Inherited disorders, inflammations, and infections that damage the spine contribute to the growth in the prevalence of spinal disorders.

According to estimates by World Spine Care, around 1 billion people worldwide suffered from spine pain. Each year, approximately 72% of the global population is expected to experience back pain, while around 59% of people are identified with back pain at any given time. Lower back pain is the primary cause of disability, and neck pain is the fourth leading cause of disability, globally, as estimated by World Spine Care.

Technological Advancements in Minimally Invasive Spine Surgery

Minimally invasive spine surgery has seen significant technological advancements in recent years. Some of the most important technological developments include employing an endoscope in spine surgery, navigation-guided spinal fusion, and O-arm navigation in spine surgery. With technical and technological advancements, MISS has expanded its utility to simple spinal stenosis and complex spinal pathologies such as metastasis, trauma, or adult spinal deformity. Robotic systems are expected to become a bigger part of spine surgery. Research and developments by key market players and stakeholders to produce innovative solutions are driving the demand in the market.

In May 2023, Globus Medical, Inc. received approval from the US Food and Drug Administration for its first humanitarian device, the REFLECT Scoliosis Correction System. The system is designed to correct progressive scoliosis in young patients while preserving motion, maintaining stability, and allowing for future modulated growth.

Dominance of Endoscopy Segment

Endoscopy technology used for minimally invasive spine surgeries is anticipated to be the leading segment. Endoscopic spinal surgeries offer advantages such as less soft tissue dissection, reduced blood loss, minimal damage to normal structures, decreased epidural scarring, shorter hospital stay, and earlier functional recovery, thus preferred over other spinal surgeries. Additionally, endoscopic spine surgery can effectively treat conditions such as herniated discs, bulging discs, foraminal stenosis, and degenerative lumbar disease. Several product launches have happened to cater to the endoscopic spinal surgery market.

In October 2023, Joimax launched a new surgical system called the iLESSYS Biportal Interlaminar Endoscopic Surgical System. The system was introduced at two major events, EUROSPINE 2023 Annual Meeting in Frankfurt and SMISS Annual Forum (Society for Minimally Invasive Spine Surgery) in Las Vegas. The iLESSYS Biportal is designed to treat spinal disorders and features a set of instruments tailor-made for biportal spinal endoscopy. One of the system's key features is that it separates the instrument's working port from the endoscope, allowing for greater flexibility and range of motion during surgery.

Ambulatory Surgical Centers to be the Fastest Growing End-user Segment

New techniques, better anesthesia, and improved pain control make same-day back surgeries outstanding growth opportunities for ambulatory settings. Owing to the advantages of ambulatory surgical centers, such as reduced hospital stays, higher success rates, and lower costs, there is an increased number of spinal surgeries being performed at ambulatory surgical centers, showing a drastic shift from preference to hospital settings to ambulatory setups. Additionally, surgeons prefer ambulatory surgical centers to reduce hospital resource utilization. Overall, the clinical advantages of outpatient spine surgery are beneficial, but it has economic advantages that are most convincing in the case of ambulatory surgical centers. For instance, the Ambulatory Surgery Center Association reports an 80% increase in surgeries performed at ASCs.

North America to Dominate the Market

The number of minimally invasive spine surgeries performed in the United States is higher than in other countries due to several factors, including the widespread employment of minimally invasive and endoscopic spinal surgery techniques by spine surgeons in the United States. While Asia is a hotspot for these techniques, the United States is renowned for its excellence in minimally invasive spine surgery, offering patients quicker recovery times, reduced pain, and minimal scarring.

Regional variations in acceptance and utilization of minimally invasive spinal surgery techniques among spine surgeons play a role, with the United States showing a high level of acceptance and utilization of these techniques. The United States being a highly contributing country in North America, helps in establishing dominance of the region in the minimally invasive spine technologies market.

Future Market Scenario (2024 - 2031F)

Accelerated development of innovative robotic-assisted spine surgeries is anticipated to exponentially expand the minimally invasive spine technologies market in the future. Regulatory emphasis on developing and approving such products drives further market expansion. For instance, in August 2023, Wenzel Spine received clearance from the US Food and Drug Administration (FDA) for its primaLOK SP system. According to the company, it marks a significant advancement in spinal fusion technology, providing surgeons and patients with a highly effective and reliable solution for spinal stabilization. The primaLOK SP system incorporates innovative engineering and patient-focused design, offering a comprehensive solution for spinal fusion procedures. The latest FDA clearance allows for the primaLOK SP system to be used at multiple levels, including the treatment of patients with lumbar spinal stenosis.

Key Players Landscape and Outlook

The key players in the minimally invasive spine technologies market are engaged in product development, strategic alliances, and business growth strategies such as partnerships, agreements, and collaborations to drive market value. Regulatory approvals for new products and services and expansion of permitted indications for existing products drive the growth of players and the market.

In May 2023, Novarad's VisAR, a surgical navigation system that employs augmented reality, gained clearance from Indonesia's FDA for intraoperative use in stereotactic spinal surgery. VisAR is effective in both open and minimally invasive surgery (MISS). Advanced technology enables surgeons to convert a patient's imaging data into a 3D hologram that can be precisely projected onto the patient's body. It helps surgeons focus purely on the surgical goal without diverting their attention to a separate monitor, allowing for accurate surgical guidance.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Minimally Invasive Spine Technologies Market Outlook, 2017-2031F

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. By Technique
  • 4.2.1. Endoscopy
  • 4.2.2. Navigation
  • 4.2.3. Robotics
• 4.3. By Condition
  • 4.3.1. Herniated Disc
  • 4.3.2. Spinal Stenosis
  • 4.3.3. Degenerative Disc Disease
  • 4.3.4. Spinal Deformity
  • 4.3.5. Spinal Fracture
  • 4.3.6. Spinal Infection
  • 4.3.7. Spinal Tumor
• 4.4. By End-user
  • 4.4.1. Hospitals
  • 4.4.2. Ambulatory Surgical Centers
  • 4.4.3. Orthopedics Clinics
• 4.5. By Region
  • 4.5.1. North America
  • 4.5.2. Europe
  • 4.5.3. Asia-Pacific
  • 4.5.4. South America
  • 4.5.5. Middle East and Africa
• 4.6. By Company Market Share (%), 2023

5. Global Minimally Invasive Spine Technologies Market Outlook, By Region, 2017-2031F

• 5.1. North America*
  • 5.1.1. Market Size & Forecast
    • 5.1.1.1. By Value
    • 5.1.1.2. By Volume
  • 5.1.2. By Technique
    • 5.1.2.1. Endoscopy
    • 5.1.2.2. Navigation
    • 5.1.2.3. Robotics
  • 5.1.3. By Condition
    • 5.1.3.1. Herniated Disc
    • 5.1.3.2. Spinal Stenosis
    • 5.1.3.3. Degenerative Disc Disease
    • 5.1.3.4. Spinal Deformity
    • 5.1.3.5. Spinal Fracture
    • 5.1.3.6. Spinal Infection
    • 5.1.3.7. Spinal Tumor
  • 5.1.4. By End-user
    • 5.1.4.1. Hospitals
    • 5.1.4.2. Ambulatory Surgical Centers
    • 5.1.4.3. Orthopedics Clinics
  • 5.1.5. United States*
    • 5.1.5.1. Market Size & Forecast
    • 5.1.5.1.1. By Value
    • 5.1.5.1.2. By Volume
    • 5.1.5.2. By Technique
    • 5.1.5.2.1. Endoscopy
    • 5.1.5.2.2. Navigation
    • 5.1.5.2.3. Robotics
    • 5.1.5.3. By Condition
    • 5.1.5.3.1. Herniated Disc
    • 5.1.5.3.2. Spinal Stenosis
    • 5.1.5.3.3. Degenerative Disc Disease
    • 5.1.5.3.4. Spinal Deformity
    • 5.1.5.3.5. Spinal Fracture
    • 5.1.5.3.6. Spinal Infection
    • 5.1.5.3.7. Spinal Tumor
    • 5.1.5.4. By End-user
    • 5.1.5.4.1. Hospitals
    • 5.1.5.4.2. Ambulatory Surgical Centers
    • 5.1.5.4.3. Orthopedics Clinics
  • 5.1.6. Canada
  • 5.1.7. Mexico

All segments will be provided for all regions and countries covered

• 5.2. Europe
  • 5.1.6. Germany
  • 5.1.7. France
  • 5.1.8. Italy
  • 5.1.9. United Kingdom
  • 5.1.10. Russia
  • 5.1.11. Netherlands
  • 5.1.12. Spain
  • 5.1.13. Turkey
  • 5.1.14. Poland
• 5.2. Asia-Pacific
  • 5.2.6. India
  • 5.2.7. China
  • 5.2.8. Japan
  • 5.2.9. Australia
  • 5.2.10. Vietnam
  • 5.2.11. South Korea
  • 5.2.12. Indonesia
  • 5.2.13. Philippines
• 5.3. South America
  • 5.3.6. Brazil
  • 5.3.7. Argentina
• 5.4. Middle East & Africa
  • 5.4.6. Saudi Arabia
  • 5.4.7. UAE
  • 5.4.8. South Africa

6. Market Mapping, 2023

• 6.1. By Technique
• 6.2. By Condition
• 6.3. By End-user
• 6.4. By Region

7. Macro Environment and Industry Structure

• 7.1. Demand Supply Analysis
• 7.2. Import Export Analysis
• 7.3. Value Chain Analysis
• 7.4. PESTEL Analysis
  • 7.4.1. Political Factors
  • 7.4.2. Economic System
  • 7.4.3. Social Implications
  • 7.4.4. Technological Advancements
  • 7.4.5. Environmental Impacts
  • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5. Porter's Five Forces Analysis
  • 7.4.7. Supplier Power
  • 7.4.8. Buyer Power
  • 7.4.9. Substitution Threat
  • 7.4.10. Threat from New Entrant
  • 7.4.11. Competitive Rivalry

8. Market Dynamics

• 8.1. Growth Drivers
• 8.2. Growth Inhibitors (Challenges and Restraints)

9. Regulatory Framework and Innovation

• 9.1. Clinical Trials
• 9.2. Patent Landscape
• 9.3. Regulatory Approvals
• 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

• 10.1. Competition Matrix of Top Five Market Leaders
• 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4. SWOT Analysis (For Five Market Players)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

• 12.1. B. Braun SE
  • 12.1.1. Company Details
  • 12.1.2. Key Management Personnel
  • 12.1.3. Products & Services
  • 12.1.4. Financials (As reported)
  • 12.1.5. Key Market Focus & Geographical Presence
  • 12.1.6. Recent Developments
• 12.2. Boston Scientific Corporation
• 12.3. Globus Medical, Inc.
• 12.4. Medtronic plc
• 12.5. Precision Spine, Inc.
• 12.6. Richard Wolf GmbH
• 12.7. Stryker Corporation
• 12.8. Intuitive Surgical, Inc.
• 12.9. Zimmer Biomet Holdings, Inc.
• 12.10. Johnson & Johnson Services, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

13. Strategic Recommendations

14. About Us & Disclaimer